Hemolytic Transfusion Reaction Due to Anti-A<sub>1</sub> Antibody During Pregnancy: Case Report.
Ontology highlight
ABSTRACT: The ABO blood group is the most clinically relevant system in transfusion medicine. Approximately 20% of individuals with blood group A of European descent belong to a weak A subgroup, most commonly A2, which may produce anti-A1 antibodies. These antibodies are usually cold-reactive IgM and rarely cause hemolysis, but can occasionally be clinically significant when reactive at 37°C. We describe a pregnant woman with sickle cell disease (HbS/β0 thalassemia) and prior hyperhemolysis syndrome who developed a severe delayed hemolytic transfusion reaction (DHTR) after transfusion of A1 red blood cells (RBCs). Anti-A1 was identified posttransfusion, confirming her as a non-A1 subtype. Notably, she also experienced hemolysis follow
SUBMITTER: Sahni S
PROVIDER: S-EPMC12615022 | biostudies-literature | 2025
REPOSITORIES: biostudies-literature
ACCESS DATA